The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cytomegalovirus Nosode · HUMAN HERPESVIRUS 5 18 [hp_X]/mL · Liquid · Oral · Deseret Biologicals, Inc
NDC 43742-1807-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotheca Company | HUMAN HERPESVIRUS 5 200 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 20 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 90 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 1000 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 120 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 500 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 15 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 30 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Apotheca Company | HUMAN HERPESVIRUS 5 150 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc | HUMAN HERPESVIRUS 5 18 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 1 [hp_M]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 10 [hp_M]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 60 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 30 [hp_X]/mL | Jul 15, 2026 | Aug 12, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 500 [hp_X]/mL | Jul 15, 2026 | Aug 12, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 90 [hp_X]/mL | Jul 15, 2026 | Aug 12, 2026 |
| Deseret Biologicals, Inc | HUMAN HERPESVIRUS 5 200 [hp_X]/mL | Jul 15, 2026 | Aug 5, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 15 [hp_X]/mL | Jul 15, 2026 | Aug 5, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 150 [hp_X]/mL | Jul 15, 2026 | Aug 5, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 20 [hp_X]/mL | Jul 15, 2026 | Aug 5, 2026 |
| Deseret Biologicals, Inc. | HUMAN HERPESVIRUS 5 1000 [hp_X]/mL | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Cyto Homo — NDC 43742-1807-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742180701.
Free to cite with attribution — see how the data is put together.